Scopus:
The first results of national antimicrobial resistance surveillance system in Turkey

dc.contributor.authorÇöplü N.
dc.contributor.authorŞimşek H.
dc.contributor.authorGür D.
dc.contributor.authorGözalan A.
dc.contributor.authorHasdemir U.
dc.contributor.authorGülay Z.
dc.contributor.authorBayramoğlu G.
dc.contributor.authorGürler N.
dc.contributor.authorAydemir Ş.
dc.contributor.authorEyigör M.
dc.contributor.authorPerçin D.
dc.contributor.authorAktaş D.
dc.date.accessioned2023-04-12T02:17:44Z
dc.date.available2023-04-12T02:17:44Z
dc.date.issued2018-01-01
dc.description.abstractObjective: In order to combat with antimicrobial resistance, some measures should be taken and determination of the current status is one of them. National antimicrobial resistance surveillance system (NAMRSS) was established for this purpose in Turkey. It was targeted to be useful for guidence of ampirical therapy, create antimicrobial usage policies, provide data to the guidebooks, and supply initial information to evaluate the efficasy of the measures taken. Methods: Data of resistance was collected from 55 hospital, from blood and cerebrospinal fluid isolates, which were S. aureus, E. faecalis and E. faecium, S. pneumoniae, E. coli, K. pneumoniae and P. aeruginosa. The antimicrobials and test methods were chosen in accordance with international surveillance systems. The collected data was analysed by WHONET software. Results: S. aureus (1437); meticillin resistance was 31.5%, rifampin, linezolid and vancomycin resistance were 65.3%, 2.3%, and 0.0%, respectively. E. faecalis (n=760) resistance of ampicillin was 9.7%, linezolid, vancomycin, teicoplanin were lower than 1%, high level (HL) aminoglycoside was around 30%. E. faecium (n=756) resistance of ampicillin was 88,1%, linezolid, teicoplanin were lower than 1%, vancomycin 17%, HL aminoglycoside was around 50%. S. pneumoniae (n=128) with non-meningitis breakpoints; resistance were lower than 5.2% for all antimicrobials other than erythromycin (32%), with meningitis breakpoints: resistance increased to 14,3-44,8%. E. coli (2280) and K. pneumoniae (1307), extended spectrum beta-lactamase (ESBL) was 51.6% and 54.0%, respectively. P. aeruginosa (825) resistance were changed in between 8.4% (amikacin) and 36.4% (piperacillin). Conclusion: The resistance was higher among the countries in close geographical region and increased in time, indicating the need for developing policies to combat with it. Besides, the results will also be valuable to monitor the usefulness of the measures taken.
dc.identifier.doi10.5505/TurkHijyen.2018.68878
dc.identifier.issn03779777
dc.identifier.scopus2-s2.0-85059467423
dc.identifier.urihttps://hdl.handle.net/20.500.12597/5367
dc.relation.ispartofTurk Hijyen ve Deneysel Biyoloji Dergisi
dc.rightstrue
dc.subjectAntimikrobiyal direnç | Drug resistance | Microbial | Surveillance | Surveyans | Turkey | Türkiye
dc.titleThe first results of national antimicrobial resistance surveillance system in Turkey
dc.typeArticle
dspace.entity.typeScopus
oaire.citation.issue4
oaire.citation.volume75
person.affiliation.nameKastamonu University
person.affiliation.nameNational Molecular Microbiology Reference Laboratory
person.affiliation.nameHacettepe Üniversitesi
person.affiliation.nameAtaturk Training and Research Hospital
person.affiliation.nameMarmara Üniversitesi
person.affiliation.nameDokuz Eylül Üniversitesi
person.affiliation.nameKaradeniz Technical University
person.affiliation.nameİstanbul Tıp Fakültesi
person.affiliation.nameEge Üniversitesi
person.affiliation.nameAkdeniz Üniversitesi
person.affiliation.nameErciyes Üniversitesi
person.affiliation.nameNational Molecular Microbiology Reference Laboratory
person.identifier.scopus-author-id6505823840
person.identifier.scopus-author-id55116271900
person.identifier.scopus-author-id7102822112
person.identifier.scopus-author-id6507067134
person.identifier.scopus-author-id6507694967
person.identifier.scopus-author-id6603856635
person.identifier.scopus-author-id24170779400
person.identifier.scopus-author-id6603761998
person.identifier.scopus-author-id8905840200
person.identifier.scopus-author-id6506040566
person.identifier.scopus-author-id33568235700
person.identifier.scopus-author-id55331994400
relation.isPublicationOfScopus6e22f090-3d96-42da-be97-03e8838fc465
relation.isPublicationOfScopus.latestForDiscovery6e22f090-3d96-42da-be97-03e8838fc465

Files